For: | Sun HC, Tang ZY. Preventive treatments for recurrence after curative resection of hepatocellular carcinoma - A literature review of randomized control trials. World J Gastroenterol 2003; 9(4): 635-640 [PMID: 12679900 DOI: 10.3748/wjg.v9.i4.635] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i4/635.htm |
Number | Citing Articles |
1 |
Cindy J. Lai, Norah A. Terrault. Antiviral therapy in patients with chronic hepatitis B and cirrhosis. Gastroenterology Clinics of North America 2004; 33(3): 629 doi: 10.1016/j.gtc.2004.05.002
|
2 |
Christiane Kulinna, Wolfgang Schima. Focal Liver Lesions. Medical Radiology 2005; : 275 doi: 10.1007/3-540-26354-3_19
|
3 |
Rinaldo Pellicano, Vincenzo Mazzaferro, Walter Franco Grigioni, Miguel Angel Cutufia, Sharmila Fagoonee, Lorenzo Silengo, Mario Rizzetto, Antonio Ponzetto. <i>Helicobacter</i> species sequences in liver samples from patients with and without hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(4): 598-601 doi: 10.3748/wjg.v10.i4.598
|
4 |
Harufumi Maki, Kiyoshi Hasegawa. Advances in the surgical treatment of liver cancer. BioScience Trends 2022; 16(3): 178 doi: 10.5582/bst.2022.01245
|
5 |
Yong-Song Guan, Qing He, Ming-Quan Wang. Transcatheter Arterial Chemoembolization: History for More than 30 Years. ISRN Gastroenterology 2012; 2012: 1 doi: 10.5402/2012/480650
|
6 |
Ignacio García-Alonso, Teodoro Palomares, Ana Alonso, Miguel Echenique-Elizondo, Juan Caramés, Begonia Castro, Jaime Méndez. Effect of Liver Resection on the Progression and Growth of Rhabdomyosarcoma Metastases in a Rat Model. Journal of Surgical Research 2008; 148(2): 185 doi: 10.1016/j.jss.2007.06.026
|
7 |
Renumathy Dhanasekaran, Roniel Cabrera. Primary Liver Cancer. 2012; : 263 doi: 10.1007/978-1-61779-863-4_14
|
8 |
Ronnie T.P. Poon. Prevention of recurrence after resection of hepatocellular carcinoma: A daunting challenge. Hepatology 2011; 54(3): 757 doi: 10.1002/hep.24569
|
9 |
Elshazly Sheta, Ferial El-Kalla, Mohamed El-Gharib, Abdelrahman Kobtan, Mohammed Elhendawy, Sherief Abd-Elsalam, Loai Mansour, Ibrahim Amer. Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled study. European Journal of Gastroenterology & Hepatology 2016; 28(10): 1198 doi: 10.1097/MEG.0000000000000688
|
10 |
Zhendong Gao, Gang Du, Yuguang Pang, Zhihao Fu, Chongzhong Liu, Yi Liu, Binghai Zhou, Du Kong, Binyao Shi, Zhengcheng Jiang, Bin Jin. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors. Medicine 2017; 96(33): e7426 doi: 10.1097/MD.0000000000007426
|
11 |
Shi-Min Luo, Li-Jian Liang, Jia-Ming Lai. Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis. World Journal of Gastroenterology 2004; 10(9): 1292-1296 doi: 10.3748/wjg.v10.i9.1292
|
12 |
Tae-Jin Song, Edmund Wai Kit Ip, Yuman Fong. Hepatocellular carcinoma: Current surgical management. Gastroenterology 2004; 127(5): S248 doi: 10.1053/j.gastro.2004.09.039
|
13 |
Changlie Zhang, Zhihong Song, Guangji Yu. High Expression of Parkin Predicts Easier Recurrence of Patients With Adjuvant Transarterial Chemoembolization. Biomarkers in Medicine 2017; 11(10): 823 doi: 10.2217/bmm-2017-0129
|
14 |
Mohamed Abdel-Wahab, Tarek Salah El-Husseiny, Ehab El Hanafy, Mohamed El Shobary, Emad Hamdy. Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver. Langenbeck's Archives of Surgery 2010; 395(6): 625 doi: 10.1007/s00423-010-0643-0
|
15 |
Jill Allen, Alan Venook. Hepatocellular carcinoma: Epidemic and treatment. Current Oncology Reports 2004; 6(3): 177 doi: 10.1007/s11912-004-0047-9
|
16 |
Donghe Chen, Chengdong Chang, Yafei Zhang, Shuye Yang, Guolin Wang, Lili Lin, Xin Zhao, Kui Zhao, Xinhui Su. Different Features of 18F-FAPI, 18F-FDG PET/CT and MRI in the Evaluation of Extrahepatic Metastases and Local Recurrent Hepatocellular Carcinoma (HCC): A Case Report and Review of the Literature. Cancer Management and Research 2022; : 2649 doi: 10.2147/CMAR.S374916
|
17 |
Valerie Fako, Xin Wei Wang. The status of transarterial chemoembolization treatment in the era of precision oncology. Hepatic Oncology 2017; 4(2): 55 doi: 10.2217/hep-2017-0009
|
18 |
Shi-Ying Xuan, Yong-Ning Xin, An-Jin Chen, Quan-Jiang Dong, Xin Qiang, Ning Li, Ming-Hua Zheng, Hua-Shi Guan. Association between the presence of <italic>H pylori</italic> in the liver and hepatocellular carcinoma: A meta-analysis. World Journal of Gastroenterology 2008; 14(2): 307-312 doi: 10.3748/wjg.14.307
|
19 |
Jian‐Hong Zhong, Le‐Qun Li. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta‐analysis. Hepatology Research 2010; 40(10): 943 doi: 10.1111/j.1872-034X.2010.00710.x
|
20 |
Zhan Hua, Jingzhou Chen, Baishun Sun, Gonghua Zhao, Yuanchun Zhang, Yuman Fong, Zhengeng Jia, Li Yao. Specific expression of osteopontin and S100A6 in hepatocellular carcinoma. Surgery 2011; 149(6): 783 doi: 10.1016/j.surg.2010.12.007
|
21 |
Ulrich-Frank Pape, Thomas Berg, Bertram Wiedenmann. Medizinische Therapie 2005|2006. 2005; : 837 doi: 10.1007/3-540-27385-9_77
|
22 |
Shi-Ying Xuan, Ning Li, Xin Qiang, Rong-Rong Zhou, Yong-Xin Shi, Wen-Jie Jiang. Helicobacter infection in hepatocellular carcinoma tissue. World Journal of Gastroenterology 2006; 12(15): 2335-2340 doi: 10.3748/wjg.v12.i15.2335
|
23 |
Roberto Santambrogio, Enrico Opocher, Massimo Zuin, Carlo Selmi, Emanuela Bertolini, Mara Costa, Matteo Conti, Marco Montorsi. Surgical Resection Versus Laparoscopic Radiofrequency Ablation in Patients With Hepatocellular Carcinoma and Child-Pugh Class A Liver Cirrhosis. Annals of Surgical Oncology 2009; 16(12): 3289 doi: 10.1245/s10434-009-0678-z
|
24 |
Xiyang Wei, Lei Zhao, Ruizhe Ren, Fubo Ji, Shuting Xue, Jianjuan Zhang, Zhaogang Liu, Zhao Ma, Xin W. Wang, Linda Wong, Niya Liu, Jiong Shi, Xing Guo, Stephanie Roessler, Xin Zheng, Junfang Ji. MiR‐125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma. Hepatology 2021; 73(4): 1381 doi: 10.1002/hep.31448
|
25 |
Ming-Chih Ho, Jen-Jen Lin, Chiung-Nien Chen, Chaur-Chin Chen, Hsinyu Lee, Ching-Yao Yang, Yen-Hsuan Ni, King-Jen Chang, Hey-Chi Hsu, Fon-Jou Hsieh, Po-Huang Lee. A Gene Expression Profile for Vascular Invasion can Predict the Recurrence After Resection of Hepatocellular Carcinoma: a Microarray Approach. Annals of Surgical Oncology 2006; 13(11): 1474 doi: 10.1245/s10434-006-9057-1
|
26 |
S G Lee, S Hwang, J P Jung, Y J Lee, K H Kim, C S Ahn. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. British Journal of Surgery 2007; 94(3): 320 doi: 10.1002/bjs.5622
|
27 |
Hae-Na Shin, Shin Hwang, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Young-Joo Lee, Sung-Gyu Lee. Role of the 1-month protocol transarterial chemoinfusion in detecting intrahepatic metastasis after resection of large hepatocellular carcinoma greater than 10 cm. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2013; 17(4): 157 doi: 10.14701/kjhbps.2013.17.4.157
|
28 |
Yong‐Bing Qian, Ju‐Bo Zhang, Wei‐Zhong Wu, Hong‐Bin Fang, Wei‐Dong Jia, Peng‐Yuan Zhuang, Bo‐Heng Zhang, Qi Pan, Yang Xu, Lu Wang, Zhao‐You Tang, Hui‐Chuan Sun. P48 is a predictive marker for outcome of postoperative interferon‐α treatment in patients with hepatitis B virus infection‐related hepatocellular carcinoma. Cancer 2006; 107(7): 1562 doi: 10.1002/cncr.22206
|
29 |
Qiang YAN, Jun NI, Guo-lei ZHANG, Xing YAO, Wen-bin YUAN, Lin ZHOU, Shu-sen ZHENG. Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence. Chinese Medical Journal 2013; 126(5): 855 doi: 10.3760/cma.j.issn.0366-6999.20121871
|
30 |
Zheng-Gang Ren, Zhi-Ying Lin, Jing-Lin Xia, Sheng-Long Ye, Zeng-Chen Ma, Qing-Hai Ye, Lun-Xiu Qin, Zhi-Quan Wu, Jia Fan, Zhao-You Tang. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control study. World Journal of Gastroenterology 2004; 10(19): 2791-2794 doi: 10.3748/wjg.v10.i19.2791
|
31 |
N. Girard, F. Mornex, C. Trepo, P. Merle. Place de la radiothérapie dans la stratégie de traitement du carcinome hépatocellulaire. Oncologie 2007; 9(6): 482 doi: 10.1007/s10269-007-0650-0
|
32 |
Tianhao Cong, Chao Yang, Qi Cao, Jinrui Ren, Yingen Luo, Pei Yuan, Bo Zheng, Yu Liu, Hongcai Yang, Wendi Kang, Aixin Ou, Xiao Li. The Role of GNMT and MMP12 Expression in Determining TACE Efficacy: Validation at Transcription and Protein Levels. Journal of Hepatocellular Carcinoma 2024; : 95 doi: 10.2147/JHC.S441179
|
33 |
Rong‐Xin Chen, Yun‐Hong Xia, Jie‐Feng Cui, Tong‐Chun Xue, Sheng‐Long Ye. Osteopontin, a single marker for predicting the prognosis of patients with tumor‐node‐metastasis stage I hepatocellular carcinoma after surgical resection. Journal of Gastroenterology and Hepatology 2010; 25(8): 1435 doi: 10.1111/j.1440-1746.2010.06277.x
|
34 |
John F Perry, Simone I Strasser, Jacob George, Geoffrey C Farrell, Geoffrey W McCaughan. Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2003; 4(12): 2175 doi: 10.1517/14656566.4.12.2175
|
35 |
|
36 |
|
37 |
Mindie H. Nguyen, Emmet B. Keeffe. General management. Best Practice & Research Clinical Gastroenterology 2005; 19(1): 161 doi: 10.1016/j.bpg.2004.11.001
|
38 |
Beatrice Gerard, Harry Bleiberg. Treatment of hepatocarcinoma. Current Oncology Reports 2004; 6(3): 184 doi: 10.1007/s11912-004-0048-8
|
39 |
|
40 |
Yongqiang Zhan, Lisha Mou, Kangwen Cheng, Chengyou Wang, Xuesong Deng, Junren Chen, Zhibing Fan, Yong Ni. Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy. Oncology Letters 2016; 12(4): 2511 doi: 10.3892/ol.2016.4975
|
41 |
Zhixiong Cai, Xiaoping Su, Liman Qiu, Zhenli Li, Xiaolou Li, Xiuqing Dong, Fuqun Wei, Yang Zhou, Liuping Luo, Geng Chen, Hengkai Chen, Yingchao Wang, Yongyi Zeng, Xiaolong Liu. Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-021-01467-8
|
42 |
Azzaroli Francesco, Accogli Esterita, Nigro Giovanni, Trerè Davide, Giovanelli Silvia, Miracolo Anna, Lodato Francesca, Montagnani Marco, Tamé Mariarosa, Colecchia Antonio, Mwangemi Constance, Festi Davide, Roda Enrico, Derenzini Massimo, Mazzella Giuseppe. Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: A prospective study on patients with HCV related cirrhosis. World Journal of Gastroenterology 2004; 10(21): 3099-3102 doi: 10.3748/wjg.v10.i21.3099
|
43 |
O. Aysun, A. Aysegul, F. Kayahan. Combined effect of epirubicin and lymphokine-activated killer cells on the resistant human breast cancer cells. Cell Biology and Toxicology 2004; 20(5): 261 doi: 10.1007/s10565-004-3471-6
|
44 |
Xiaohong Chen, Boheng Zhang, Xin Yin, Zhenggang Ren, Shuangjian Qiu, Jian Zhou. Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection. Journal of Cancer Research and Clinical Oncology 2013; 139(5): 773 doi: 10.1007/s00432-012-1343-7
|
45 |
Maurizio Chiriva-Internati, Fabio Grizzi, Cynthia A Jumper, Everardo Cobos, Paul L Hermonat, Eldo E Frezza. Immunological treatment of liver tumors. World Journal of Gastroenterology 2005; 11(42): 6571-6576 doi: 10.3748/wjg.v11.i42.6571
|
46 |
Lian Li, Bo Li, Ming Zhang. Postoperative adjuvant transarterial chemoembolization improves the prognosis of hepatocellular carcinoma patients with microvascular invasion: a systematic review and meta-analysis. Acta Radiologica 2020; 61(6): 723 doi: 10.1177/0284185119878357
|
47 |
Shigeki Nakagawa, Yo-ichi Yamashita, Naoki Umezaki, Takanobu Yamao, Takayoshi Kaida, Yukiharu Hiyoshi, Kosuke Mima, Hirohisa Okabe, Hiromitsu Hayashi, Katsunori Imai, Akira Chikamoto, Hideo Baba. Four gene intrahepatic metastasis–risk signature predicts hepatocellular carcinoma malignant potential and early recurrence from intrahepatic metastasis. Surgery 2021; 169(4): 903 doi: 10.1016/j.surg.2020.09.032
|
48 |
Jian-Min Qin. Postoperative recurrent factors and therapeutic and preventive strategies for hepatocellular carcinoma. World Chinese Journal of Digestology 2019; 27(23): 1407 doi: 10.11569/wcjd.v27.i23.1407
|
49 |
Liming Wang, Weihu Wang, Xuesong Yao, Weiqi Rong, Fan Wu, Bo Chen, Mei Liu, Shengtao Lin, Yunhe Liu, Jianxiong Wu. Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion. Oncotarget 2017; 8(45): 79971 doi: 10.18632/oncotarget.20402
|
50 |
Ulrich-Frank Pape, Thomas Berg, Bertram Wiedenmann. Medizinische Therapie 2007 | 2008. 2007; : 921 doi: 10.1007/978-3-540-48554-4_77
|
51 |
Jian-Hong Zhong, Liang Ma, Le-Qun Li. Postoperative therapy options for hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2014; 49(6): 649 doi: 10.3109/00365521.2014.905626
|
52 |
Jun-Gong Zhao, Gan-Sheng Feng, Xiang-Quan Kong, Xin Li, Ming-Hua Li, Ying-Sheng Cheng. Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging. World Journal of Gastroenterology 2004; 10(8): 1152-1156 doi: 10.3748/wjg.v10.i8.1152
|